gastroenteritis

Vaxart’s Oral Norovirus Vaccine Misses Primary Endpoint But Shows Some Efficacy In Phase 2

Vaxart finds itself in a precarious position as it grapples with mixed results for its oral monovalent norovirus vaccine candidate, ...